Tight junctions contain oligomeric protein assembly critical for

Frontiers Tight Junction Proteins and Signaling Pathways in

Pharmaceutics, Free Full-Text

Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke

Fingolimod reduces circulating tight-junction protein levels and in vitro peripheral blood mononuclear cells migration in multiple sclerosis patients

IJMS, Free Full-Text

Cells, Free Full-Text

Molecular components of the tight junction. Tight junctions are

Usefulness of a humanized tricellular static transwell blood–brain barrier model as a microphysiological system for drug development applications. - A case study based on the benchmark evaluations of blood-brain barrier microphysiological system

PDF) Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood-Brain Barrier Damage in Early Ischemic Stroke Stage

Target specific tight junction modulators - ScienceDirect

Tight Junction Protein - an overview

PDF] Molecular physiology and pathophysiology of tight junctions I

Molecular structure of the tight junction (TJ). Molecules like

Tempol modulates changes in xenobiotic permeability and occludin oligomeric assemblies at the blood-brain barrier during inflammatory pain

Impairment of blood-brain barrier is an early event in R6/2 mouse model of Huntington Disease